GS-4321 PLACEBO
GS-US-567-6968
Phase 2 small_molecule active
Quick answer
GS-4321 PLACEBO for Chronic Hepatitis Delta. is a Phase 2 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- Chronic Hepatitis Delta.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active